Researchers are excited about the medication , a novel dual agonist showing remarkable results in initial trials for weight loss . It functions by impacting two pathways : GLP-1 and GIP, these, when https://sashatqtd761458.educationalimpactblog.com/62301233/a-new-possibility-for-size-loss